HAVN Life Sciences Inc. (HAVLF)

USD 0.0

(-90.0%)

Long Term Debt Summary of HAVN Life Sciences Inc.

  • HAVN Life Sciences Inc.'s latest annual long term debt in 2023 was - CAD , down -100.0% from previous year.
  • HAVN Life Sciences Inc.'s latest quarterly long term debt in 2024 Q1 was - CAD , down 0.0% from previous quarter.
  • HAVN Life Sciences Inc. reported annual long term debt of 310.18 Thousand CAD in 2022, down -4.67% from previous year.
  • HAVN Life Sciences Inc. reported annual long term debt of 325.38 Thousand CAD in 2021, down 0.0% from previous year.
  • HAVN Life Sciences Inc. reported quarterly long term debt of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • HAVN Life Sciences Inc. reported quarterly long term debt of - CAD for 2023 Q1, down -100.0% from previous quarter.

Annual Long Term Debt Chart of HAVN Life Sciences Inc. (2023 - 2020)

Historical Annual Long Term Debt of HAVN Life Sciences Inc. (2023 - 2020)

Year Long Term Debt Long Term Debt Growth
2023 - CAD -100.0%
2022 310.18 Thousand CAD -4.67%
2021 325.38 Thousand CAD 0.0%
2020 - CAD 0.0%

Peer Long Term Debt Comparison of HAVN Life Sciences Inc.

Name Long Term Debt Long Term Debt Difference
Bioxytran, Inc. - USD NaN%
Eiger BioPharmaceuticals, Inc. - USD NaN%
Institute of Biomedical Research Corp. - USD NaN%
SQZ Biotechnologies Company 20.9 Million USD 100.0%
Intellipharmaceutics International Inc. - USD NaN%
Evofem Biosciences, Inc. 8000.00 USD 100.0%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 100.0%
Propanc Biopharma, Inc. 58.64 Thousand USD 100.0%
Marizyme, Inc. 667.12 Thousand USD 100.0%
Genus plc 228.2 Million USD 100.0%
Pharming Group N.V. 166.1 Million USD 100.0%
Therapeutic Solutions International, Inc. 5512.00 USD 100.0%
CNBX Pharmaceuticals Inc. - USD NaN%
Nymox Pharmaceutical Corporation - USD NaN%
ContraFect Corporation 2.21 Million USD 100.0%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 100.0%
IMV Inc. 27.39 Million USD 100.0%
AXIM Biotechnologies, Inc. 5.42 Million USD 100.0%
ONE Bio Corp. 592.19 Thousand USD 100.0%
RVL Pharmaceuticals plc 55.61 Million USD 100.0%
Mesoblast Limited 100.29 Million USD 100.0%
MultiCell Technologies, Inc. 36.43 USD 100.0%
Arno Therapeutics, Inc. - USD NaN%
Emmaus Life Sciences, Inc. 2.22 Million USD 100.0%
Genscript Biotech Corporation 287.12 Million USD 100.0%
Neon Bloom, Inc. - USD NaN%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 100.0%
Nanobac Pharmaceuticals, Incorporated - USD NaN%
Biomind Labs Inc. - USD NaN%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD 100.0%
Oncotelic Therapeutics, Inc. 1.89 Million USD 100.0%
Skye Bioscience, Inc. 171.23 Thousand USD 100.0%
GlobeStar Therapeutics Corporation - USD NaN%
VioQuest Pharmaceuticals, Inc. - USD NaN%
THC Farmaceuticals, Inc. - USD NaN%
PsyBio Therapeutics Corp. - USD NaN%
Arch Therapeutics, Inc. - USD NaN%
Sienna Biopharmaceuticals, Inc. - USD NaN%
Acro Biomedical Co., Ltd. - USD NaN%
Accustem Sciences Inc. - USD NaN%
EV Biologics, Inc. - USD NaN%
Q BioMed Inc. - USD NaN%
GB Sciences, Inc. 322 Thousand USD 100.0%
Alpha Cognition Inc. - USD NaN%
CSL Limited 11.23 Billion USD 100.0%
Agentix Corp. - USD NaN%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 100.0%
Enzolytics Inc. - USD NaN%
TetraLogic Pharmaceuticals Corporation - USD NaN%
Resverlogix Corp. - USD NaN%
Nuo Therapeutics, Inc. 164.2 Thousand USD 100.0%
MetaStat, Inc. - USD NaN%
Curative Biotechnology, Inc. - USD NaN%
argenx SE 15.35 Million USD 100.0%
Northwest Biotherapeutics, Inc. 20.31 Million USD 100.0%
HST Global, Inc. - USD NaN%
Enzon Pharmaceuticals, Inc. - USD NaN%
Wesana Health Holdings Inc. - USD NaN%
Halberd Corporation 150 Thousand USD 100.0%
Endonovo Therapeutics, Inc. - USD NaN%
Inhibitor Therapeutics, Inc. - USD NaN%
Zenith Capital Corp. 4456.00 USD 100.0%
RespireRx Pharmaceuticals Inc. - USD NaN%
GeneThera, Inc. - USD NaN%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 100.0%
AVAX Technologies, Inc. - USD NaN%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 100.0%
Cotinga Pharmaceuticals Inc. - USD NaN%
Ember Therapeutics, Inc. - USD NaN%
Anthera Pharmaceuticals, Inc. - USD NaN%
Adynxx, Inc. - USD NaN%
NovAccess Global Inc. - USD NaN%
Helix BioMedix, Inc. - USD NaN%
Capstone Therapeutics Corp. 8.26 Million USD 100.0%
Kadimastem Ltd 229.69 Thousand USD 100.0%
VitaSpring Biomedical Co. Ltd. - USD NaN%
BioStem Technologies, Inc. 265.63 Thousand USD 100.0%
Oncology Pharma Inc. - USD NaN%
Reve Technologies, Inc. 1064.00 USD 100.0%
Burzynski Research Institute, Inc. - USD NaN%
LadRx Corporation - USD NaN%
Cell Source, Inc. - USD NaN%
ProtoKinetix, Incorporated - USD NaN%
Regen BioPharma, Inc. 149.61 Thousand USD 100.0%
Regen BioPharma, Inc. 149.61 Thousand USD 100.0%
Affymax, Inc. - USD NaN%
Mobile Lads Corp. - USD NaN%
Itoco Inc. - USD NaN%
Rasna Therapeutics, Inc. - USD NaN%
Pathfinder Cell Therapy, Inc. - USD NaN%
International Stem Cell Corporation 445 Thousand USD 100.0%
CytoDyn Inc. 141 Thousand USD 100.0%
Claritas Pharmaceuticals, Inc. - USD NaN%
NDT Pharmaceuticals Inc. - USD NaN%
NanoSphere Health Sciences Inc. - USD NaN%
Qrons Inc. 80 Thousand USD 100.0%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 100.0%
SYBLEU INC 300 Thousand USD 100.0%
Advanced Proteome Therapeutics Corporation - USD NaN%
Nascent Biotech, Inc. - USD NaN%
Rebus Holdings, Inc. - USD NaN%
GlobeImmune, Inc. - USD NaN%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 100.0%
Predictive Technology Group, Inc. - USD NaN%
ProText Mobility, Inc. - USD NaN%
Cardax, Inc. - USD NaN%
VG Life Sciences Inc. - USD NaN%
Kaleido Biosciences, Inc. - USD NaN%
Advaxis, Inc. 8.15 Million USD 100.0%
Adhera Therapeutics, Inc. - USD NaN%
RenovaCare, Inc. - USD NaN%
Regnum Corp. - USD NaN%
Innovation Pharmaceuticals Inc. 457 Thousand USD 100.0%
Neutra Corp. - USD NaN%
Windtree Therapeutics, Inc. 1.16 Million USD 100.0%
PureTech Health plc 18.25 Million USD 100.0%
Coeptis Therapeutics, Inc. 150 Thousand USD 100.0%
IXICO plc 275 Thousand USD 100.0%
IntelGenx Technologies Corp. 11.83 Million USD 100.0%
Gelesis Holdings, Inc. 26.3 Million USD 100.0%
CSL Limited 11.23 Billion USD 100.0%
Cellectis S.A. 36.21 Million USD 100.0%